Noven Pharmaceuticals, Inc.

Quick facts

Phase 3 pipeline

• Diclofenac sodium active topical patch · Pain Management / Rheumatology
  Diclofenac sodium is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX) enzymes to reduce prostaglandin synthesis, thereby decreasing inflammation and pain when applied topically.

Phase 2 pipeline

• d-Amphetamine Transdermal Patch
• Diclofenac Sodium Active Topical Patch 1 · Pain Management
  Diclofenac Sodium is a non-selective COX-2 inhibitor.
• Diclofenac Sodium Active Topical Patch 2 · Pain Management
  Diclofenac Sodium is a non-selective COX-2 inhibitor.

Phase 1 pipeline

• HP-1050 Patch
• HP-5000 Topical Patch

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Noven Pharmaceuticals, Inc. portfolio CI brief
• Noven Pharmaceuticals, Inc. pipeline updates RSS